Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms

Abstract

Pancreatic neuroendocrine neoplasms (pNENs) are rare and highly heterogeneous tumors originating from pluripotent stem cells with neuroendocrine differentiation in the pancreas, constituting approximately 3% of all pancreatic tumors. [1] The global incidence of pNENs has been increasing recently, and most cases are sporadic and more common in women. [1,2] Feng Jiao and Jiujie Cui contributed equally to this work.